ABSTRACT
Persistent injuries and chronic inflammation paired with dysregulated healing process in the lungs leads to scarring and stiffening of the tissue leading to a condition called pulmonary fibrosis. There is no efficacious therapy against the condition because of the poorly understood pathophysiology of the disease. Curcumin is well known anti-inflammatory natural compound and is shown to have beneficial effects in many diseases. It is also reported to show antifibrotic activities in pulmonary fibrosis. There are evidences that fibrinolytic system plays a crucial role in the development of pulmonary fibrosis. We aimed to see whether curcumin could regulate inflammation and fibrinolysis in murine model of pulmonary fibrosis. We prepared BLM induced pulmonary fibrosis model by administering BLM at a dose of 2 mg/ kg bodyweight. Curcumin (75 mg/kg body wt) was instilled intraperitoneally on different time points. The effect of curcumin on inflammatory cytokines and fibrinolytic system was studied using molecular biology techniques like RT-PCR, western blot and immunohistochemistry/immunofluorescence. We observed that BLM brought changes in the expressions of components in the fibrinolytic system, i.e. BLM favoured fibrin deposition by increasing the expression of PAI-1 (plasminogen activator inhibitor) and decreasing the expression of uPA (Urokinase plasminogen activator) and uPAR (Urokinase plasminogen activator receptor). We also demonstrate that curcumin could restore the normal expression of fibrinolytic components, uPA, uPAR and PAI-1. Curcumin could also minimize the expression of key enzymes in tissue remodeling in pulmonary fibrosis, MMP-2 and MMP-9, which were elevated in the BLM treated group. Our data suggest that curcumin exerts an anti-inflammatory and antifibrotic effect in lungs. We highlight curcumin as a feasible adjuvant therapy option against pulmonary fibrosis.
Subject(s)
Curcumin , Pulmonary Fibrosis , Animals , Curcumin/pharmacology , Curcumin/therapeutic use , Cytokines , Fibrinolysis/physiology , Inflammation , Mice , Plasminogen Activator Inhibitor 1/genetics , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/drug therapy , Urokinase-Type Plasminogen Activator/metabolismABSTRACT
Polymer nanogels (NGs) are water-swellable, cross-linked 3D network structures with size typically range from 1 to 1000 nm. Especially, biocompatible and "smart" NGs engineered from stimuli-responsive polymers are attractive because of its capability to respond the endogenous biological triggers of pH, bioreduction, biomolecule recognition, as well as the exogenous stimuli-triggers like temperature and light. Importantly, on exposing to these physical or biochemical signals, the responsive NGs can be utilized for therapeutic delivery and diagonostic applications. In the past decade, substantial developments were achieved in the development of "smart" NGs for theranostic and diagnostic applications such as intracellular delivery of drug and nucleic acids, photodynamic/photothermal therapy, bioimaging and sensing. Herein, we exclusively review the recent exciting developments in synthetic methods as well as biomedical applications of successfully employed "smart" NGs which can respond to a single, dual or multiple stimulus- responsive triggers. The prospects in the application of the stimuli-responsive and multifunctional NGs also will be addressed in this review.
Subject(s)
Drug Carriers , Gene Transfer Techniques , Molecular Imaging , Nanogels , Neoplasms/diagnostic imaging , Neoplasms/therapy , Stimuli Responsive Polymers/chemistry , Theranostic Nanomedicine , Animals , Humans , Hydrogen-Ion Concentration , Light , Neoplasms/genetics , Stimuli Responsive Polymers/radiation effects , TemperatureABSTRACT
Injectable, drug-releasing hydrogel scaffolds with multifunctional properties including hemostasis and anti-bacterial activity are essential for successful wound healing; however, designing ideal materials is still challenging. Herein, we demonstrate the fabrication of a biodegradable, temperature-pH dual responsive supramolecular hydrogel (SHG) scaffold based on sodium alginate/poly(N-vinyl caprolactam) (AG/PVCL) through free radical polymerization and the subsequent chemical and ionic cross-linking. A natural therapeutic molecule, tannic acid (TA)-incorporated SHG (AG/PVCL-TA), was also fabricated and its hemostatic and wound healing efficiency were studied. In the AG/PVCL-TA system, TA acts as a therapeutic molecule and also substitutes as an effective gelation binder. Notably, the polyphenol-arm structure and diverse bonding abilities of TA can hold polymer chains through multiple bonding and co-ordinate cross-linking, which were vital in the formation of the mechanically robust AG/PVCL-TA. The SHG formation was successfully balanced by varying the composition of SA, VCL, TA and cross-linkers. The AG/PVCL-TA scaffold was capable of releasing a therapeutic dose of TA in a sustained manner under physiological temperature-pH conditions. AG/PVCL-TA displayed excellent free radical scavenging, anti-inflammatory, anti-bacterial, and cell proliferation activity towards the 3T3 fibroblast cell line. The wound healing performance of AG/PVCL-TA was further confirmed in skin excision wound models, which demonstrated the potential application of AG/PVCL-TA for skin regeneration and rapid wound healing.